Covid-19 has upended the business models of many entrepreneurs in India, who now have to find a way around the various challenges brought by the pandemic
Total COVID-19 confirmed cases worldwide stood at 146,830,782 with 31,06,384 deaths.
Natco Pharma has applied to the Central Drugs Standard Control Organization (CDSCO) in India for approval of Phase-III clinical trial of Molnupiravir Capsules for the treatment of COVID-19 positive patients.
The 14th season of the league, like in the past, has thrills, adventures, disappointments and some lessons for the equity investors
The active cases have increased to 28,13,658 comprising 16.25 per cent of the total infections, while the national COVID-19 recovery rate has further dropped to 82.62 per cent
The stock hit a 52-week high of Rs 4,850 on 17 March 2021. The stock hit a 52-week low of Rs 872 on 23 April 2020.
28 out of 30 Sensex stocks are opened in the green. ICICI Bank gained over 4% on the back of strong Q4 numbers
The scrip was up 0.81% at Rs 1919.80 at around 9.25 am (IST). On the other hand, the benchmark Benchmark BSE Sensex was up 516 points, or 1.13%, at 48,417 at around the same time.
The delivery took place from the naval base in Kochi.